1. What do data in monoinfection mean in relation to co-infection?

3. Treatment of Chronic Hepatitis C

5. Telaprevir and Boceprevir SVR by patient Type

6. SVR Rates With BOC or TVR in GT1 Treatment-Experienced Patients

7. Futility Rules for BOC or TVR + PegIFN/RBV

9. Telaprevir + PR: Adverse Events

11. Boceprevir + PR: Adverse Events

12. Practical Strategies: Managing Anemia

13. Telaprevir: SVR Rates by RBV Dose Reduction in ADVANCE and ILLUMINATE

14. Boceprevir: SVR in Pts With Hb < 10 g/dL by EPO and/or RBV Dose Reduction

15. Adverse Effect Management: Anaemia

17. My patient (SS)

18. Accepted for Boceprevir EAP

19. Viral Response and Tolerability

20. Viral Response and Tolerability

21. King’s cohort n=20: adverse effects

25. New HCV agents : What are the possible challenges?